Joseph Mesa, MD
Orthopaedic Surgery · Wilmington, DENPI 1083660187
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,304 of the $13,305 with a category attached, or 62.4%. 18 manufacturers reported payments, led by Arthrex at 51.3% of the total. Reporting peaked in 2019 at $4,703 and has fallen 95.7% since, to $201 in 2025.
Across 112 payments — averaging $118.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$7K
- Liberty Surgical Inc.$5K
- Eclipse Technology Solutions Inc.$728
- Amgen$259
- Zimmer Biomet$128
- Stryker$113
- plus $450 from 12 others
What the payments were for
- Travel & lodging$2,04115%
- Food & beverage$2,96022%
- Education$8,30462%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 26 | $6,829 |
| Liberty Surgical Inc. | 25 | $4,797 |
| Eclipse Technology Solutions Inc. | 20 | $728 |
| Amgen | 14 | $259 |
| Zimmer Biomet | 2 | $128 |
| Stryker | 4 | $113 |
| Next Science LLC | 2 | $100 |
| Electronic Waveform Lab, Inc. | 5 | $91 |
| Ferring Pharmaceuticals Inc. | 3 | $40 |
| Johnson & Johnson | 2 | $39 |
| Fidia Pharma USA Inc. | 2 | $38 |
| Vertex | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Avanos Medical | 1 | $24 |
| Bioventus LLC | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $18 |
| Synergy Orthopedics, LLC | 1 | $17 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PENNSAID$110
How this compares
$13,305 in reported general payments places this provider in the 65th percentile of 70 orthopaedic surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 30 | $739 |
| Oxycodone Hcl | 79 | $415 |
| Meloxicam | 101 | $293 |
| Cyclobenzaprine Hcl | 32 | $241 |
| Cephalexin | 42 | $178 |
| Naproxen | 11 | $161 |
| Methylprednisolone | 23 | $130 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $107 |
| Ibuprofen | 14 | $87 |
| Tramadol Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wilmington
- Suken ShahWilmington$2.1M
- Patrick WardWilmington$68K
- Steven DelloseWilmington$52K
- James RubanoWilmington$39K
- Nicholas QuercettiWilmington$32K
- Michael PrincipeWilmington$29K
- David TainterWilmington$26K
- Akul PatelWilmington$21K
- Alfonso ArevaloWilmington$18K
- Michael ShraderWilmington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.